Xcout Intel
Element Genomics, Inc. competitors & alternatives
The 12 closest competitors and alternatives to Element Genomics, Inc. among biotech companies — ranked by similarity to what Element Genomics, Inc. actually does, not by market-cap band.
Subscribe to see Element Genomics, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Element Genomics, Inc.
Element Genomics was a Duke-founded biotechnology startup established in 2015 to develop computational tools and CRISPR-based approaches for understanding gene regulation. Based in Durham, North Carolina, the company was subsequently acquired by UCB to strengthen its research capabilities.
Element Genomics, Inc. at a glance
Element Genomics, Inc. is a biotech company headquartered in United States. Its most recent funding round, Series A, raised $4.8M in November 2016. Xcout tracks 15 named people at Element Genomics, Inc., including Logan Zinser (CFO). Xcout recorded 29 job postings from Element Genomics, Inc. in the last 90 days.
Element Genomics, Inc. leadership
- Logan ZinserCFO
- Brian StolzChief People Officer
- David MelaughGeneral Counsel
- Molly HeCEO, Co-Founder, and Board Member
- Michael PreviteCTO and SVP of Advanced Research, Co-Founder
- Matthew KellingerSVP of Product Strategy and Co-Founder
9 more named people on record for Element Genomics, Inc., with roles, board committees and tenure — see the full roster →
Element Genomics, Inc. funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series A | $4.8M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Hiring at Element Genomics, Inc.
Xcout recorded 29 job postings from Element Genomics, Inc. in the last 90 days, from a hiring record Xcout has kept since July 2026.
The weekly hiring trend, the roles and locations behind it — see Element Genomics, Inc.'s hiring signals →
Top 12 Element Genomics, Inc. competitors
Ranked by semantic similarity — how close each company is to Element Genomics, Inc. by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Biotechnology
Enhanced Genomics Ltd. is a functional genomics company headquartered in Cambridge, United Kingdom. The firm utilizes its proprietary 3D multi-omics genomics technology to uncover causal biology behind genetic variation and transform drug target discovery.
Biotechnology
Fauna Bio is a biotechnology company headquartered in Berkeley, California. The company combines animal genomics and advanced data approaches to drive drug discovery and improve human health.
Similar biotech company
Variant Bio, Inc. is a biotechnology company that uses human genomic diversity and population genetics to discover therapeutic targets and develop medicines. It works with researchers, healthcare and biotechnology partners, and genetically diverse communities to study traits associated with health and disease.
Life Sciences
Broken String Biosciences is a biotechnology research company headquartered in Cambridge, England, operating out of Little Chesterford. The company develops advanced platforms dedicated to powering the future of gene editing safety and development.
Biotechnology
Shift Bioscience is a biotechnology research company based in Cambridge, United Kingdom, that employs generative AI virtual cell models to understand gene activation and cellular reprogramming.
Similar biotech company
Verge Genomics develops a proprietary AI and machine learning platform utilizing human brain data to transform neuroscience drug discovery and precision neurology. The company provides foundation models and analytical tools to pharmaceutical and biotechnology developers for target discovery, biomarker identification, and clinical trial patient stratification.
Biotechnology
SwitchPoint Bio Holding, Inc. operates a platform that combines precision epigenomics and artificial intelligence to analyze cellular biology from blood samples. The company provides biomarker discovery, patient stratification, and treatment response mechanism readouts to support drug development and clinical research.
Similar biotech company
Dyno Therapeutics is a biotechnology research company headquartered in Watertown, Massachusetts, specializing in gene therapy delivery solutions using artificial intelligence.
Similar biotech company
Voyager Therapeutics, Inc. operates as a gene therapy company, concentrating its efforts on developing innovative treatments and pioneering advanced platform technologies. Its leading clinical asset, VY-AADC, is presently undergoing an open-label Phase 1 clinical trial for the management of Parkinson's disease. The company's preclinical portfolio is extensive, featuring VY-SOD102 for amyotrophic lateral sclerosis (ALS), VY-HTT01 for Huntington's disease, and VY-FXN01 for Friedreich's ataxia. Additionally, Voyager is pursuing a Tau program aimed at various tauopathies, including Alzheimer's disease, progressive supranuclear palsy, and frontotemporal dementia, alongside initiatives for spinal muscular atrophy. To advance its gene therapy product pipeline, the company has forged strategic collaboration and licensing agreements with key industry players such as Neurocrine Biosciences, Inc., Pfizer Inc., and Novartis Pharma, A.G. These partnerships cover the research, development, and commercialization of adeno-associated virus-based gene therapy products. Voyager Therapeutics, Inc. was founded in 2013 and maintains its corporate headquarters in Cambridge, Massachusetts.
Similar biotech company
Form Bio is a computational life sciences company headquartered in San Carlos, California, providing AI-driven software solutions for genetic medicines and multi-species genome engineering.
Similar biotech company
Deep Genomics is a biotechnology research company that collaborates across disciplines to solve complex molecular design challenges. The company's corporate headquarters are located in Toronto, Ontario, Canada, a hub for innovation.
Healthcare
Dicerna Pharmaceuticals was a biotechnology company that developed RNA interference (RNAi) therapeutics using its proprietary GalXC platform. It focused on medicines for patients with rare, chronic liver, cardiovascular, and metabolic diseases, and was acquired by Novo Nordisk in 2021.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Element Genomics, Inc. and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Element Genomics, Inc.and every competitor above — in one live dashboard.
Subscribe to Xcout Intel →